Evidence map›Paper›PMID 39242394›Full record

ArticleInternational orthopaedics2024

Three-dimensional virtual reality-assisted surgical planning for neuronavigated sacrectomy of a chordoma: a technical note.

Luca Paun, Alexandre Lavé, Granit Molliqaj, Julien Haemmerli, Carlo M Oranges, Dennis E Dominguez, Nicolas Buchs, Maria Isabel Vargas, Enrico Tessitore

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luca PaunDivision of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland. lucapaun@gmail.com.ORCID 0000-0002-1120-0441
Alexandre LavéDivision of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Granit MolliqajDivision of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Julien HaemmerliDivision of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Carlo M OrangesDivision of Plastic and Reconstructive Surgery, Geneva University Hospitals, University of Geneva Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Dennis E DominguezSpine Team, Division of Orthopedics and Trauma Surgery, Geneva University Hospitals, University of Geneva Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Nicolas BuchsDivision of Digestive Surgery, Geneva University Hospitals and University of Geneva Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Maria Isabel VargasDivision of Diagnostic Neuroradiology, Geneva University Hospitals and University of Geneva Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.
Enrico TessitoreDivision of Neurosurgery, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Faculty of Medicine, 4 Rue Gabrielle-Perret-Gentil, Geneva, 1205, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSacral chordomas are slow growing but locally aggressive tumours with a high rate of local recurrence if not completely removed. Surgical resection with negative margins represents the most important survival predictor but it can be challenging to accomplish. Thanks to improvements in intraoperative imaging and surgical techniques, en bloc resection through a partial sacral resection with wide surgical margins has become feasible but it comes with a significant morbidity rate. In this technical note we detail the virtual reality-assisted surgical planning used during resection.

methodsA 70-year-old patient underwent en bloc resection of the tumor by an antero-posterior two-stage surgery approach. Pre-operatively, based on MR- and CT-imaging, virtual objects were designed, representing the tumour, the surrounding bone and the neurovascular structures. This 3D-model was used to plan the well delimited partial sacral resection and the posterior surgical approach. Intraoperatively the instruments were registered, allowing for a real-time visualization of the tumor, of the neurovascular structures, and for an optimal margin control resection.

resultsPostoperatively the patient was intact in the lower extremities, without any deficit up to S1 roots. An intentional middle-low sacral amputation of S2-S5 roots was necessary to have a wide resection with free margins. At follow-up, the patient did not present any lower extremities motor deficit with an improvement of sensory function on S1 dermatome.

conclusionThree-dimensional virtual reality-assisted surgical planning for neuronavigated sacrectomy in chordoma is useful, feasible and safe. This technology can increase surgeon's chances to perform a larger margin-free resection decreasing the risk of neurovascular damage.

Indexed as

ChordomaImaging, Three-DimensionalSacrumSpinal NeoplasmsVirtual RealityAgedHumansMagnetic Resonance ImagingNeuronavigationSurgery, Computer-AssistedTomography, X-Ray ComputedChordomaPlastic surgeryReconstructive surgerySacrectomyTractographyVirtual reality-assisted surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.